RxDoctor Payments Data

Amanda Thurmes, OD

Optometrist · New Prague, MNNPI 1821519356

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (52.1%), travel and lodging and entertainment — rather than concentrated in one kind of arrangement. Johnson & Johnson Vision Care, Inc. accounts for 60.7% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $1,679 and has fallen 86.8% since, to $222 in 2025. Among optometrist clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,206in general payments, 2019–2025

Across 41 payments — averaging $53.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson Vision Care, Inc.$1K
  • Alcon$384
  • Optos, Inc.$237
  • Coopervision Inc.$148
  • Glaukos Corporation$41
  • Oyster Point Pharma, Inc.$29
  • plus $27 from 3 others

What the payments were for

  • Travel & lodging$81837%
  • Food & beverage$1,15052%
  • Entertainment$23711%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,206 in reported general payments places this provider in the 90th percentile of 826 optometrist providers in Minnesota.

See all optometrist providers in Minnesota

Medicare billing

Part B allowed, 2024
$20,044
Medicare patients
126
Services billed
1,034

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate68$2,291
Latanoprost87$977
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha31$392
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat16$218

Paid to pharmacies, not to this prescriber.

Other optometrist in New Prague

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →